Synthesis and anticonvulsant activity of some 1-substituted-2- oxopyrrolidine derivatives, II

Medicinal Chemistry Research

Volumn 9, Issue 9, 1999, Pages 696-721

  Al Obaid, Abdulrahman M ^a   El Subbagh, Hussein I ^a   Al Shabanah, Othman A ^a   Elmazar, Mohamed M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; N (4 FLUOROBENZYL) 2 (2 OXOPYRROLIDIN 1 YL)ACETAMIDE; N (4 METHOXYBENZYL) 2 (2 OXOPYRROLIDIN 1 YL)ACETAMIDE; N (PHENYLETHYL) 2 (2 OXOPYRROLIDIN 1 YL)ACETAMIDE; N [2 (4 FLUOROPHENYL)ETHYL] 2 (2 OXOPYRROLIDIN 1 YL)ACETAMIDE; PENTETRAZOLE; PICROTOXIN; PRODRUG; PYRROLIDINE DERIVATIVE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DOSE CALCULATION; DRUG SAFETY; DRUG SYNTHESIS; ELECTRIC SHOCK; FEMALE; LIPOPHILICITY; MALE; MOUSE; NONHUMAN; SEDATION;

EID: 0033508957     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. (1) Shoravon, S.D. Lancet 1990, 336, 93-96.
2. (2) Bordie, M.J. Lancet 1990, 336, 350-354.
3. (3) Meldrum, B.S., Porter, R.J., Eds. In New Anticonvulsant Drugs. Current Problems in Epilepsy 4; John Libby: London, 1986.
4. (4) Flaherty, P.T.; Greenwood, T.D.; Manheim, A.L.; Wolfe, J.F. J. Med. Chem. 1996, 39, 1509-1513.
5. (5) Jacobsen, E.J.; Tenbrink, R E.; Stelzer, L.S.; Belonga, K.L. J. Med Chem., 1996, 39, 158-175.
6. (6) Reddy, P.A.; Woodward, K.E.; McIlheran, S.M.; Hsiang, C. H; Latifi, T.N.; Covey, D.F.J. Med Chem. 1997, 40, 44-49.
7. (7) Monn, J.A.; Valli, M.J.; Massey, S.M.; Wright, R A.; Salhoff, C.R.; Johnson, B.G.; Rhodes, G.A.; Tizzano, J.P.; Schoepp, D.D. J. Med. Chem. 1997, 40, 528-537.
8. (8) Larsen, P.K.; Frouland, B.; Jorgensen, F.S.; Schousboe, A. J. Med. Chem. 1994, 37, 2489-2505.
9. (9) Jacob, J.N.; Schashoua, V.E.; Campbell, A.A.; Baldessorini, R.J. J. Med. Chem., 1985, 28, 106-110.
10. (10) Jacob, J.N.; Hesse, G.W.; Shashoua, V.E. J. Med. Chem. 1987, 30, 1573-1578.
11. (11) Kaplan, J.P.; Raizon, B.M.; Desarmenien, M.; Feltz, P.; Headly, P.M., Worms, P.; Lloyd, K.; Bartholini, G. J. Med Chem. 1980, 23, 702-704.
12. (12) Sasaki, H.; Mori, J.; Nakamura J. Med Chem. 1991, 34, 628-630.
13. (13) El-Subbagh, H.I.; Nasr, M.A.; Abdelal, A.M.; Gineinah, MM.; El-Kashef, H.A. Med. Chem. Res. 1994, 4, 335-345.
14. (14) Bardel, P.; Bolanos, A.; Kohn, H. J. Med Chem. 1994, 37, 4567.
15. (15) Malawska, B.; Gorezyca, M. Pol. J. Chem. 1985, 59, 811-818.
16. (16) Kadushkin, A.V.; Golovko, T.V.; Granik, V.G.; Glushkov, R.G., Parimbetova, R.B.; et al. Pharm. Chem. J. 1989, 23, 10, 803-806.
17. (17) Löscher, W.; Nau, H. Neuropharmacology, 1985, 24, 427-435.
18. (18) Elmazar, M.M.A.; Hauck, R.-S.; Nau, H. J. Pharm. Sci, 1993, 82, 1255-1258.
19. (19) White, H.S.; Woodhead, J.H; Franklin, M.R.; Swinyard, E.A.; Wolf, H.H. In Antiepileptic Drugs, 4th ed.; Levy, R.H.; Mattson, R.H.; Meldrum, B.S.; Eds, Raven: New York, 1995, pp 99-121.
20. (20) Litchfield, J.T. Jr.; Wilcoxon, F. J. Pharm. Exp. Ther. 1949, 96, 99-113.
21. (21) Swinyard, E.A.; Woodhead, J.H. In Antiepileptic Drugs, 2nd ed.; Woodbury, D.M., Penny, J.K., Pippenger, CE., Eds, Raven Press: New York, 1982, pp 111-126.
22. (22) Boissier, J.R.; Tardy, J.; Diverres, J.C. Med. Exp. Basel 1960, 3, 81-84.
23. (23) Ghose, A.K.; Crippen, G.M. J. Chem. Inf. Comput. Sci., 1987, 27, 21-35.